AliveGen USA, Inc., founded in 2014, is a privately held clinical-stage biopharmaceutical company located in Thousand Oaks, California.
AREA OF FOCUS
We are focused on the discovery and development of novel biotherapeutics with first-in-class and best-in-class potential to combat diseases of high unmet medical need, including cardiovascular diseases, neuromuscular disorders, blood disorders, chronic kidney disease, fibrosis, inflammation, bone disorders, and cancer.
We aspire to improve the care and quality of life of patients by developing innovative therapies that are both highly effective and safe. To achieve this goal, we are developing a pipeline of novel next-generation clinical candidates using cutting-edge biotechnology.